Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

HS TECH Index Earning Revision (Aug): Kuaishou, XPENG, XIAOMI, BIDU, LI AUTO, SMIC

HS TECH Index Earning Revision (Sep): BIDU, TONGCHENG TRAVEL, TRIP.COM, MINIMAX, Kuaishou, LI AUTO

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

<ul>
<li>HS TECH September 2026 review announced one ADD and one DELETE.</li>
<li>Iluvatar Corex enters and Tongcheng Travel leaves, effective 7 Sep 2026.</li>
<li>Both names fell into the announcement in the pre-announcement window. Historically, comparable ADDs kept rising after the open, and comparable DELETEs rebounded after announcement day.</li>
</ul>


HS TECH September 2026 review announced one ADD and one DELETE.
Iluvatar Corex enters and Tongcheng Travel leaves, effective 7 Sep 2026.
Both names fell into the announcement in the pre-announcement window. Historically, comparable ADDs kept rising after the open, and comparable DELETEs rebounded after announcement day.


HS TECH Sep 2026 Index Rebalance: Post-Announcement Positioning

Iluvatar CoreX

HS TECH Sep 2026 Index Rebalance: Post-Announcement Positioning